FBLN2 and breast carcinoma: In contrast to a suppressive role in breast cancer, experimental studies from other organs have suggested that fibulin-2 may contribute to metastases and invasion in lung and pancreatic adenocarcinoma cell lines [23, 24], suggesting organ specific properties of fibulin-2.